{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:47:35Z","timestamp":1792691255040,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00066-014-0610-8","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T08:49:23Z","timestamp":1394009363000},"page":"485-490","source":"Crossref","is-referenced-by-count":36,"title":["Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer","Radiotherapie f\u00fcr Patienten mit isoliertem lokalem Rezidiv eines prim\u00e4r resezierten Pankreaskarzinoms"],"prefix":"10.1007","volume":"190","author":[{"given":"Akira","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Itasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Takaori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mizowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"issue":"9","key":"610_CR1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00066-013-0391-5","volume":"189","author":"SE Combs","year":"2013","unstructured":"Combs SE, Habermehl D, Kessel K et al (2013) Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer: outcome analysis and comparison with a 3D-treated patient cohort. Strahlenther Onkol 189:738\u2013744","journal-title":"Strahlenther Onkol"},{"key":"610_CR2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1748-717X-8-27","volume":"8","author":"D Habermehl","year":"2013","unstructured":"Habermehl D, Brecht IC, Bergmann F et al (2013) Chemoradiation in patients with isolated recurrent pancreatic cancer therapeutical efficacy and probability of re-resection. Radiat Oncol 8:27","journal-title":"Radiat Oncol"},{"issue":"1\u20132","key":"610_CR3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cell.2011.11.060","volume":"148","author":"H Haeno","year":"2012","unstructured":"Haeno H, Gonen M, Davis MB et al (2012) Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148:362\u2013375","journal-title":"Cell"},{"issue":"4","key":"610_CR4","first-page":"466","volume":"14","author":"A Hamidian Jahromi","year":"2013","unstructured":"Hamidian Jahromi A, Sangster G, Zibari G et al (2013) Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 Levels in detecting recurrent pancreatic adenocarcinoma. JOP 14:466\u2013468","journal-title":"JOP"},{"issue":"3\u20134","key":"610_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000236022","volume":"77","author":"K Hashimoto","year":"2009","unstructured":"Hashimoto K, Ueno H, Ikeda M et al (2009) Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment? Oncology 77:217\u2013223","journal-title":"Oncology"},{"issue":"17","key":"610_CR6","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","volume":"362","author":"M Hidalgo","year":"2010","unstructured":"Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362:1605\u20131617","journal-title":"N Engl J Med"},{"issue":"4","key":"610_CR7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","volume":"10","author":"S Hishinuma","year":"2006","unstructured":"Hishinuma S, Ogata Y, Tomikawa M et al (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10:511\u2013518","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"610_CR8","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","volume":"27","author":"CA Iacobuzio-Donahue","year":"2009","unstructured":"Iacobuzio-Donahue CA, Fu B, Yachida S et al (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27:1806\u20131813","journal-title":"J Clin Oncol"},{"key":"610_CR9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","volume":"120","author":"MH Kalser","year":"1985","unstructured":"Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899\u2013903","journal-title":"Arch Surg"},{"issue":"4","key":"610_CR10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.sla.0000245845.06772.7d","volume":"245","author":"J Kleeff","year":"2007","unstructured":"Kleeff J, Reiser C, Hinz U et al (2007) Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg 245:566\u2013572","journal-title":"Ann Surg"},{"key":"610_CR11","doi-asserted-by":"crossref","unstructured":"Klinkenbijl JH, Jeekel J, Sahmoud T et al (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776\u2013782, discussion 782\u2013784","DOI":"10.1097\/00000658-199912000-00006"},{"key":"610_CR12","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(01)06651-X","volume":"358","author":"JP Neoptolemos","year":"2001","unstructured":"Neoptolemos JP, Dunn JA, Stocken DD et al (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358:1576\u20131585","journal-title":"Lancet"},{"issue":"12","key":"610_CR13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200\u20131210","journal-title":"N Engl J Med"},{"key":"610_CR14","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B","volume":"59","author":"[no authors listed]","year":"1987","unstructured":"[no authors listed] (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer 59:2006\u20132010","journal-title":"Cancer"},{"issue":"2","key":"610_CR15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/SLA.0b013e3182827a65","volume":"258","author":"M Oshima","year":"2013","unstructured":"Oshima M, Okano K, Muraki S et al (2013) Immunohistochemically detected expression of 3 major genes (CDKN2A\/p16, TP53, and SMAD4\/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Ann Surg 258:336\u2013346","journal-title":"Ann Surg"},{"issue":"9","key":"610_CR16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.299.9.1019","volume":"299","author":"WF Regine","year":"2008","unstructured":"Regine WF, Winter KA, Abrams RA et al (2008) Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 299:1019\u20131026","journal-title":"JAMA"},{"issue":"3","key":"610_CR17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000219332","volume":"26","author":"MH Seelig","year":"2009","unstructured":"Seelig MH, Janot M, Chromik AM et al (2009) Redo-surgery following curative resection of pancreatic carcinoma: the difference between true and suspected recurrence. Dig Surg 26:222\u2013228","journal-title":"Dig Surg"},{"key":"610_CR18","doi-asserted-by":"crossref","unstructured":"Strobel O, Hartwig W, Hackert T et al Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol 20:964\u2013972","DOI":"10.1245\/s10434-012-2762-z"},{"issue":"6","key":"610_CR19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.6004\/jnccn.2012.0073","volume":"10","author":"MA Tempero","year":"2012","unstructured":"Tempero MA, Arnoletti JP, Behrman SW et al (2012) Pancreatic adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 10:703\u2013713","journal-title":"J Natl Compr Canc Netw"},{"key":"610_CR20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/biomet\/77.1.147","volume":"77","author":"TM Therneau","year":"1990","unstructured":"Therneau TM, Grambsch PM, Fleming TR (1990) Martingale-based residuals for survival models. Biometrika 77:147\u2013160","journal-title":"Biometrika"},{"issue":"9","key":"610_CR21","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11605-012-1912-8","volume":"16","author":"RM Thomas","year":"2012","unstructured":"Thomas RM, Truty MJ, Nogueras-Gonzalez GM et al (2012) Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg 16:1696\u20131704.","journal-title":"J Gastrointest Surg"},{"key":"610_CR22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejso.2008.12.006","volume":"35","author":"A Van den Broeck","year":"2009","unstructured":"Van den Broeck A, Sergeant G, Ectors N et al (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol; 35:600","journal-title":"Eur J Surg Oncol"},{"issue":"29","key":"610_CR23","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1200\/JCO.2010.30.3446","volume":"28","author":"JL Van Laethem","year":"2010","unstructured":"Van Laethem JL, Hammel P, Mornex F et al (2010) Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013\u201322012\/FFCD-9203\/GERCOR phase II study. J Clin Oncol 28:4450\u20134456","journal-title":"J Clin Oncol"},{"issue":"1","key":"610_CR24","first-page":"34","volume":"7","author":"R Wilkowski","year":"2006","unstructured":"Wilkowski R, Thoma M, Bruns C et al (2006) Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. JOP 7:34\u201340","journal-title":"JOP"},{"issue":"2","key":"610_CR25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/SLA.0b013e31827fe9ce","volume":"258","author":"JM Winter","year":"2013","unstructured":"Winter JM, Tang LH, Klimstra DS et al (2013) Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression. Ann Surg 258:331\u2013335","journal-title":"Ann Surg"},{"issue":"7","key":"610_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00066-013-0343-0","volume":"189","author":"H Yoon","year":"2013","unstructured":"Yoon H, Oh D, Park HC et al (2013) Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma. Strahlenther Onkol 189:541\u2013546","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"610_CR27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00066-011-0002-2","volume":"188","author":"C Zamboglou","year":"2012","unstructured":"Zamboglou C, Messmer MB, Becker G et al (2012) Stereotactic radiotherapy in the liver hilum. Basis for future studies. Strahlenther Onkol 188:35\u201341","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"610_CR28","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00432-012-1165-7","volume":"138","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Frampton AE, Kyriakides C et al (2012) Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy. J Cancer Res Clin Oncol 138:1063\u20131071","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-014-0610-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-014-0610-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-014-0610-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T04:58:01Z","timestamp":1565240281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-014-0610-8"}},"subtitle":["Prolonged disease-free interval associated with favorable prognosis","Verl\u00e4ngerte krankheitsfreie Zeit mit besserer Prognose assoziiert"],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1007\/s00066-014-0610-8","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}